Abstract
The Frascati criteria for HIV-associated neurocognitive disorders (HAND; Antinori et al. 2007) outlines a classification scheme for functional decline that—despite being over a decade old—has not heretofore been examined systematically. Participants included 307 HIV+ and 183 HIV− participants who completed self-report, clinician-rated, and performance-based measures of functional status, along with neurocognitive, psychiatric, and medical/laboratory assessments. Using the Frascati criteria, we classified participants with (1) no functional declines, (2) mild functional declines, or (3) major functional declines. A multivariable logistic regression showed that HIV serostatus was associated with higher rates of major (33.2 vs. 13.7%) but not mild (38.8 vs. 31.7%) Frascati-defined functional decline. Within the HIV+ group, individuals with global neurocognitive impairment and affective disorders were at highest risk of Frascati-defined functional decline. Findings provide some empirical support for the sensitivity and validity of the Frascati criteria for functional declines in the context of HAND. Future work is needed to determine the reliability, stability, cross-cultural validity, and downstream health-related consequences of the Frascati-defined functional classifications.
Similar content being viewed by others
References
American Psychiatric Association (2013) DSM-5 task force. Diagnostic and statistical manual of mental disorders: DSM-5, 5th edn. APA, Washington, DC, pp 44–947
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799
Bearden DR, Meyer AC (2016) Should the Frascati criteria for HIV-associated neurocognitive disorders be used in children? Neurology 87:17–18
Benedict RH, Mezhir JJ, Walsh K, Hewitt RG (2000) Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Arch Clin Neuropsychol 15(6):535–544
Blackstone K, Moore DJ, Heaton RK, Franklin DR, Woods SP, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S (2012) Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc 18(1):79–88
Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore DJ, Franklin DR, Ellis RJ, Grant I, Woods SP, Translational Methamphetamine ARCG (2013) Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use. J Addict Med 7:255–263
Brandt CP, Sheppard DP, Zvolensky MJ, Morgan EE, Atkinson JH, Woods SP (2016) Does age influence the frequency of anxiety symptoms and disorders in HIV disease? J HIV AIDS Soc Serv 15(4):380–403
Brandt CP, Zvolensky MJ, Woods SP, Gonzalez A, Safren SA, O'Cleirigh CM (2017) Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literature. Clin Psychol Rev 51:164–184
Burns SM, Young LR, Maniss S (2006) Predictors of employment and disability among people living with HIV/AIDS. Rehabil Psychol 51(2):127
Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26(3):307–319
Casaletto KB, Umlauf A, Beaumont J, Gershon R, Slotkin J, Akshoomoff N, Heaton RK (2015) Demographically corrected normative standards for the English version of the NIH Toolbox Cognition Battery. J Int Neuropsychol Soc 21(5):378–391
Casaletto KB, Weber E, Iudicello JE, Woods SP (2017) Real-world impact of HIV-associated neurocognitive impairment. In: Changes in the brain. Springer, New York, NY, pp 211–245
Doyle KL, Morgan EE, Morris S, Smith DM, Little S, Iudicello JE, Blackstone K, Moore DJ, Grant I, Letendre SL, Woods SP (2013) Real-world impact of neurocognitive deficits in acute and early HIV infection. J Neurovirol 19(6):565–573
Erlandson KM, Schrack JA, Jankowski CM, Brown TT, Campbell TB (2014) Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep 11(3):279–290
Garre-Olmo J, Vilalta-Franch J, Calvó-Perxas L, López-Pousa S, CoDep-AD Study Group (2017) A path analysis of dependence and quality of life in Alzheimer’s disease. Am J Alzheimers Dis Other Dement 32(2):108–115. https://doi.org/10.1177/1533317516688297
Gisslén M, Price RW, Nilsson S (2011) The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis 11(1):356
Grant I, Franklin DR, Deutsch R, Woods SP, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Collier AC, Marra CM (2014) Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 82(23):2055–2062
Heaton RK, Miller S, Taylor M, Grant I (2004a) Revised comprehensive norms for an expanded Halstead-Reitan Battery: demographically adjusted neuropsychological norms for African American and Caucasian adults scoring program. Psychological Assessment Resources, Odessa, FL
Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I (2004b) The impact of HIV- associated neuropsychological impairment on everyday function- ing. J Int Neuropsychol Soc 10:317–331
Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75(23):2087–2096
Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, Thrasher D, Goetz MB, Stefaniak M (2002) Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 59(12):1944–1950
Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, Stefaniak M (2004) Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS (London, England) 18(Suppl 1):S19
Hollingshead AB (1975) Four factor index of social status. Unpublished manuscript, Yale University, Department of Sociology, New Haven
Hoogendijk EO, Romero L, Sánchez-Jurado PM, Ruano TF, Viña J, Rodríguez-Mañas L, Abizanda P (2019) A New Functional Classification Based on Frailty and Disability Stratifies the Risk for Mortality Among Older Adults: The FRADEA Study. J Am Med Dir Assoc. https://doi.org/10.1016/j.jamda.2019.01.129
Jacks A, Wainwright DA, Salazar L, Grimes R, York M, Strutt AM, Shahani L, Woods SP, Hasbun R (2015) Neurocognitive deficits increase risk of poor retention in care among older adults with newly diagnosed HIV infection. AIDS 29(13):1711–1714
Janssen RS, Cornblath DR, Epstein LG, Foa RP (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. (1991). Neurology 41(6):778–785
Kamat R, Weinborn M, Kellogg EJ, Bucks RS, Velnoweth A, Woods SP (2014) Construct Validity of the memory for Intentions Screening Test (MIST) in healthy older adults. Assessment 21(6):742–753
Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: Maclead CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205
Kordovski VM, Woods SP, Verduzco M, Beltran J (2017) The effects of aging and HIV disease on employment status and functioning. Rehabil Psychol 62(4):591
Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3_Part_1):179–186
Malaspina L, Woods SP, Moore DJ, Depp C, Letendre SL, Jeste D, Grant I, HIV Neurobehavioral Research Programs (HNRP) Group (2011) Successful cognitive aging in persons living with HIV infection. J Neurovirol 17(1):110–119
Marcotte TD, Wolfson T, Rosenthal TJ, Heaton RK, Gonzalez R, Ellis RJ, Grant I, HIV Neurobehavioral Research Center Group (2004) A multimodal assessment of driving performance in HIV infection. Neurology 63(8):1417–1422
McIntosh RC, Ironson G, Antoni M, Kumar M, Fletcher MA, Schneiderman N (2014) Alexithymia is linked to neurocognitive, psychological, neuroendocrine, and immune dysfunction in persons living with HIV. Brain Behav Immun 36:165–175
McNair DM, Lorr M, Droppleman L (1981) Profile of mood states questionnaire. EDITS, San Diego, CA
Morgan EE, Woods SP, Smith C, Weber E, Scott JC, Grant I, HIV Neurobehavioral Research Program (HNRP) Group (2012) Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND). AIDS Behav 16(8):2279–2285
Naseer M, Forssell H, Fagerström C (2016) Malnutrition, functional ability and mortality among older people aged ⩾ 60 years: a 7-year longitudinal study. Eur J Clin Nutr 70(3):399–404. https://doi.org/10.1038/ejcn.2015.196
O'cleirigh C, Ironson G, Fletcher MA, Schneiderman N (2008) Written emotional disclosure and processing of trauma are associated with protected health status and immunity in people living with HIV/AIDS. Br J Health Psychol 13(1):81–84
Rabkin JG, McElhiney M, Ferrando SJ, Van Gorp W, Lin SH (2004) Predictors of employment of men with HIV/AIDS: a longitudinal study. Psychosom Med 66(1):72–78
Sheppard DP, Woods SP, Massman PJ, Gilbert PE (2019) Frequency and correlates of subjective cognitive impairment in HIV disease. AIDS Behav 23(3):617–626
Smith G, Della Sala S, Logie RH, Maylor EA (2000) Prospective and retrospective memory in normal ageing and dementia: A questionnaire study. Memory 8:311–321
Thames AD, Becker BW, Marcotte TD, Hines LJ, Foley JM, Ramezani A, Singer EJ, Castellon SA, Heaton RK, Hinkin CH (2011a) Depression, cognition, and self-appraisal of functional abilities in HIV: An examination of subjective appraisal versus objective performance. Clin Neuropsychol 25(2):224–243
Thames AD, Kim MS, Becker BW, Foley JM, Hines LJ, Singer EJ, Heaton RK, Castellon SA, Hinkin CH (2011b) Medication and finance management among HIV-infected adults: the impact of age and cognition. J Clin Exp Neuropsychol 33(2):200–209
Thames AD, Arentoft A, Rivera-Mindt M, Hinkin CH (2013) Functional disability in medication management and driving among individuals with HIV: a 1-year follow-up study. J Clin Exp Neuropsychol 35(1):49–58
Tierney SM, Sheppard DP, Kordovski VM, Faytell MP, Avci G, Woods SP (2017) A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders. J Neurovirol 23(3):404–421
Tierney SM, Woods SP, Sheppard D, Ellis RJ (2019) Extrapyramidal motor signs in older adults with HIV disease: frequency, 1-year course, and associations with activities of daily living and quality of life. J Neurovirol 25(2):162–173
Weber E, Blackstone K, Iudicello JE, Morgan EE, Grant I, Moore DJ, Woods SP, Translational Methamphetamine AIDS Research Center (TMARC) Group (2012) Neurocognitive deficits are associated with unemployment in chronic methamphetamine users. Drug Alcohol Depend 125(1-2):146–153
Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26(6):759–778
Woods SP, Iudicello JE, Morgan EE, Cameron MV, Doyle KL, Smith TV, Cushman C, HIV Neurobehavioral Research Program (HNRP) Group, Grant I, Atkinson JH, Ellis RJ (2016) Health-related everyday functioning in the internet age: HIV-associated neurocognitive disorders disrupt online pharmacy and health chart navigation skills. Arch Clin Neuropsychol 31(2):176–185
Woods SP, Iudicello JE, Morgan EE, Verduzco M, Smith TV, Cushman C, The HNRP Group (2017) Household everyday functioning in the Internet age: online shopping and banking skills are affected in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc 23:605–615
World Health Organization (1998) Composite International Diagnostic Interview (CIDI,Version 2.128). World Health Organization, Geneva, Switzerland
Acknowledgments
This work was supported by the National Institutes of Health under Grants R01-MH073419, P30-MH62512, and R21-MH098607. The authors are grateful to the UC San Diego HIV Neurobehavioral Research Program (HNRP) Group (I. Grant, PI) for their infrastructure support of the parent R01. In particular, we thank Donald Franklin, Dr. Erin Morgan, Clint Cushman, and Stephanie Corkran for their assistance with data processing, Marizela Verduzco for her assistance with study management, Drs. Scott Letendre and Ronald J. Ellis for their assistance with the neuromedical aspects of the parent project, and Dr. J. Hampton Atkinson and Jennifer Marquie Beck and their assistance with participant recruitment and retention. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, nor the United States Government. The authors thank the study volunteers for their participation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Matchanova, A., Woods, S.P. & Kordovski, V.M. Operationalizing and evaluating the Frascati criteria for functional decline in diagnosing HIV-associated neurocognitive disorders in adults. J. Neurovirol. 26, 155–167 (2020). https://doi.org/10.1007/s13365-019-00809-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-019-00809-z